NX-13 clinical trials

A Randomized, Double-Blind, Placebo-Controlled, Multiple Dose, Multicenter Phase 2 Induction Study with Long-Term Extension to Evaluate the Clinical Activity and Safety of Oral NX-13 in Participants with Moderate to Severe Ulcerative Colitis

This study is testing a new medicine called NX-13 for people in the UK with moderate to severe ulcerative colitis. Researchers want to see if it helps reduce symptoms and is safe compared to a dummy pill.